Search details
1.
The prognostic significance of a negative PSMA-PET scan prior to salvage radiotherapy following radical prostatectomy.
Eur J Nucl Med Mol Imaging
; 51(2): 558-567, 2024 Jan.
Article
in English
| MEDLINE | ID: mdl-37736808
2.
PSMA-PET/CT-guided salvage radiotherapy in recurrent or persistent prostate cancer and PSA < 0.2 ng/ml.
Eur J Nucl Med Mol Imaging
; 50(8): 2529-2536, 2023 07.
Article
in English
| MEDLINE | ID: mdl-36905411
3.
Cardiac late effects after modern 3D-conformal radiotherapy in breast cancer patients: a retrospective cohort study in Germany (ESCaRa).
Breast Cancer Res Treat
; 191(1): 147-157, 2022 Jan.
Article
in English
| MEDLINE | ID: mdl-34626275
4.
Radiotherapy for hormone-sensitive prostate cancer with synchronous low burden of distant metastases.
Strahlenther Onkol
; 198(8): 683-689, 2022 08.
Article
in English
| MEDLINE | ID: mdl-35704054
5.
[PSMA-PET-MRI and radio-guided surgery in cervical lymphadenectomy]. / PSMA-PET und "radio-guided surgery" bei zervikaler Lymphadenektomie.
HNO
; 70(12): 907-910, 2022 Dec.
Article
in German
| MEDLINE | ID: mdl-35829724
6.
Moderately hypofractionated radiotherapy as definitive treatment for localized prostate cancer: Pattern of practice in German-speaking countries : A survey of the Prostate Cancer Expert Panel of the German Society of Radiation Oncology (DEGRO) and the Working Party on Radiation Oncology of the German Cancer Society (DKG-ARO).
Strahlenther Onkol
; 197(11): 993-1000, 2021 Nov.
Article
in English
| MEDLINE | ID: mdl-34463814
7.
Radiotherapy in nodal oligorecurrent prostate cancer.
Strahlenther Onkol
; 197(7): 575-580, 2021 07.
Article
in English
| MEDLINE | ID: mdl-33914101
8.
Ultrahypofractionation of localized prostate cancer : Statement from the DEGRO working group prostate cancer.
Strahlenther Onkol
; 197(2): 89-96, 2021 Feb.
Article
in English
| MEDLINE | ID: mdl-33301049
9.
Value of PET imaging for radiation therapy.
Strahlenther Onkol
; 197(9): 1-23, 2021 09.
Article
in English
| MEDLINE | ID: mdl-34259912
10.
Termination rates and histological reclassification of active surveillance patients with low- and early intermediate-risk prostate cancer: results of the PREFERE trial.
World J Urol
; 39(1): 65-72, 2021 Jan.
Article
in English
| MEDLINE | ID: mdl-32189088
11.
Oncological outcome and recurrence pattern analysis after involved-field irradiation in combination with rituximab for early-stage nodal and extranodal follicular lymphoma.
Strahlenther Onkol
; 196(8): 705-714, 2020 Aug.
Article
in English
| MEDLINE | ID: mdl-32377821
12.
Treatment strategies to prevent and reduce gynecomastia and/or breast pain caused by antiandrogen therapy for prostate cancer : Statement from the DEGRO working group prostate cancer.
Strahlenther Onkol
; 196(7): 589-597, 2020 Jul.
Article
in English
| MEDLINE | ID: mdl-32166452
13.
Role of combined radiation and androgen deprivation therapy in intermediate-risk prostate cancer : Statement from the DEGRO working group on prostate cancer.
Strahlenther Onkol
; 196(2): 109-116, 2020 Feb.
Article
in English
| MEDLINE | ID: mdl-31784804
14.
Interobserver variability, detection rate, and lesion patterns of 68Ga-PSMA-11-PET/CT in early-stage biochemical recurrence of prostate cancer after radical prostatectomy.
Eur J Nucl Med Mol Imaging
; 47(10): 2339-2347, 2020 09.
Article
in English
| MEDLINE | ID: mdl-32157427
15.
The impact of prostate-specific antigen persistence after radical prostatectomy on the efficacy of salvage radiotherapy in patients with primary N0 prostate cancer.
BJU Int
; 124(5): 785-791, 2019 11.
Article
in English
| MEDLINE | ID: mdl-31220400
16.
The addition of pelvic lymph node treatment to prostate bed salvage radiotherapy.
Lancet
; 400(10356): 883-884, 2022 09 17.
Article
in English
| MEDLINE | ID: mdl-36116475
17.
Salvage radiotherapy in prostate cancer patients with biochemical relapse after radical prostatectomy : Prolongation of prostate-specific antigen doubling time in patients with subsequent biochemical progression.
Strahlenther Onkol
; 194(4): 325-332, 2018 04.
Article
in English
| MEDLINE | ID: mdl-29255924
18.
Use of androgen deprivation and salvage radiation therapy for patients with prostate cancer and biochemical recurrence after prostatectomy.
Strahlenther Onkol
; 194(7): 619-626, 2018 07.
Article
in English
| MEDLINE | ID: mdl-29383406
19.
Prostate-specific antigen after salvage radiotherapy for postprostatectomy biochemical recurrence predicts long-term outcome including overall survival.
Acta Oncol
; 57(3): 362-367, 2018 Mar.
Article
in English
| MEDLINE | ID: mdl-28816074
20.
Postoperative radiotherapy in prostate cancer.
Lancet
; 397(10285): 1623, 2021 05 01.
Article
in English
| MEDLINE | ID: mdl-33933203